Environmental exposures and pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how environmental factors (like pollutants and lifestyle) may affect pulmonary hypertension. You will fill out questionnaires and provide a small hair sample to help understand these exposures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed type of pulmonary hypertension (pre-capillary) diagnosed by a heart catheter test done within the last year.
- Your type must be either pulmonary arterial hypertension (PAH) that is not linked to other diseases, or chronic thromboembolic pulmonary hypertension (CTEPH).
- You must be able to read and understand French to fill out questionnaires.
- You must have hair longer than 2 cm for sampling.
- You must not be under legal protection (e.g., guardianship) or hospitalized for severe heart failure at the time of enrollment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to validate a questionnaire that measures how well patients understand pulmonary hypertension. If you have been diagnosed with Group 1 Pulmonary Arterial Hypertension (PAH) and can read the questionnaire, you may be able to help researchers make sure it's a useful tool.
This observational study is looking at people diagnosed with pulmonary hypertension to better understand how it behaves over time. You may help researchers by allowing repeated check-ins for years and sharing symptom and test information.
This study looks at the genes that may be linked to pulmonary hypertension. By providing a saliva sample and filling out a health survey from home, you can help researchers learn more about this condition.
This study looks at lung tissue from surgery to learn how pulmonary hypertension (high blood pressure in the lungs) develops in people with lung disease. The goal is to find better ways to diagnose and treat this condition.
This study tracks natural changes in “biomarkers” (measurable signals in blood) and imaging findings in people with pulmonary arterial hypertension (PAH) or suspected PAH. It also includes healthy people for comparison, helping researchers understand what these signals mean over time.
This study collects blood and tissue samples from people with pulmonary hypertension (PH), a condition of high blood pressure in the lungs. The samples are used for research to better understand PH and possibly improve future treatments.
Hear when a new Pulmonary Arterial Hypertension (PAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.